pubmed-article:12182856 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12182856 | lifeskim:mentions | umls-concept:C0003402 | lld:lifeskim |
pubmed-article:12182856 | lifeskim:mentions | umls-concept:C0004153 | lld:lifeskim |
pubmed-article:12182856 | lifeskim:mentions | umls-concept:C0078056 | lld:lifeskim |
pubmed-article:12182856 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
pubmed-article:12182856 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
pubmed-article:12182856 | lifeskim:mentions | umls-concept:C0243077 | lld:lifeskim |
pubmed-article:12182856 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
pubmed-article:12182856 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
pubmed-article:12182856 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
pubmed-article:12182856 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
pubmed-article:12182856 | pubmed:issue | 18 | lld:pubmed |
pubmed-article:12182856 | pubmed:dateCreated | 2002-8-16 | lld:pubmed |
pubmed-article:12182856 | pubmed:abstractText | A series of novel phenolic compounds has been discovered as potent inhibitors of TNF-alpha-inducible expression of vascular cell adhesion molecule-1 (VCAM-1) with concurrent antioxidant and lipid-modulating properties. Optimization of these multifunctional agents led to the identification of 3a (AGI-1067) as a clinical candidate with demonstrated efficacies in animal models of atherosclerosis and hyperlipidemia. | lld:pubmed |
pubmed-article:12182856 | pubmed:language | eng | lld:pubmed |
pubmed-article:12182856 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12182856 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:12182856 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12182856 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12182856 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12182856 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12182856 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12182856 | pubmed:month | Sep | lld:pubmed |
pubmed-article:12182856 | pubmed:issn | 0960-894X | lld:pubmed |
pubmed-article:12182856 | pubmed:author | pubmed-author:Parthasarathy... | lld:pubmed |
pubmed-article:12182856 | pubmed:author | pubmed-author:MengCharles... | lld:pubmed |
pubmed-article:12182856 | pubmed:author | pubmed-author:SomersPatrici... | lld:pubmed |
pubmed-article:12182856 | pubmed:author | pubmed-author:RachitaCaroly... | lld:pubmed |
pubmed-article:12182856 | pubmed:author | pubmed-author:HoltLisa ALA | lld:pubmed |
pubmed-article:12182856 | pubmed:author | pubmed-author:HoongLee KLK | lld:pubmed |
pubmed-article:12182856 | pubmed:author | pubmed-author:ZhengX... | lld:pubmed |
pubmed-article:12182856 | pubmed:author | pubmed-author:SimpsonJacob... | lld:pubmed |
pubmed-article:12182856 | pubmed:author | pubmed-author:HillRussell... | lld:pubmed |
pubmed-article:12182856 | pubmed:author | pubmed-author:OlliffLynda... | lld:pubmed |
pubmed-article:12182856 | pubmed:author | pubmed-author:KunschCharles... | lld:pubmed |
pubmed-article:12182856 | pubmed:author | pubmed-author:SundellCynthi... | lld:pubmed |
pubmed-article:12182856 | pubmed:author | pubmed-author:SaxenaUdayU | lld:pubmed |
pubmed-article:12182856 | pubmed:author | pubmed-author:SikorskiJames... | lld:pubmed |
pubmed-article:12182856 | pubmed:author | pubmed-author:WassermanMart... | lld:pubmed |
pubmed-article:12182856 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12182856 | pubmed:day | 16 | lld:pubmed |
pubmed-article:12182856 | pubmed:volume | 12 | lld:pubmed |
pubmed-article:12182856 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12182856 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12182856 | pubmed:pagination | 2545-8 | lld:pubmed |
pubmed-article:12182856 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:12182856 | pubmed:meshHeading | pubmed-meshheading:12182856... | lld:pubmed |
pubmed-article:12182856 | pubmed:meshHeading | pubmed-meshheading:12182856... | lld:pubmed |
pubmed-article:12182856 | pubmed:meshHeading | pubmed-meshheading:12182856... | lld:pubmed |
pubmed-article:12182856 | pubmed:meshHeading | pubmed-meshheading:12182856... | lld:pubmed |
pubmed-article:12182856 | pubmed:meshHeading | pubmed-meshheading:12182856... | lld:pubmed |
pubmed-article:12182856 | pubmed:meshHeading | pubmed-meshheading:12182856... | lld:pubmed |
pubmed-article:12182856 | pubmed:meshHeading | pubmed-meshheading:12182856... | lld:pubmed |
pubmed-article:12182856 | pubmed:year | 2002 | lld:pubmed |
pubmed-article:12182856 | pubmed:articleTitle | Novel phenolic antioxidants as multifunctional inhibitors of inducible VCAM-1 expression for use in atherosclerosis. | lld:pubmed |
pubmed-article:12182856 | pubmed:affiliation | AtheroGenics, Inc., 8995 Westside Parkway, GA 30004, Alpharetta, USA. cmeng@atherogenics.com | lld:pubmed |
pubmed-article:12182856 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:12182856 | lld:chembl |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12182856 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12182856 | lld:pubmed |